Exelixis Inc Dl 01 (EX9)
TG
The current EX9 market cap is 10.11B. The company's latest EPS is USD 0.7275 and P/E is 50.02.
Year End December 28 2023 | 2020 | 2021 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 967.78M | 987.54M | 1.43B | 1.61B | 1.83B |
Operating Income | 369.47M | 110.06M | 286.67M | 201.48M | 170.89M |
Net Income | 321.01M | 111.78M | 231.06M | 182.28M | 207.77M |
Year End December 28 2023 | 2020 | 2021 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.89B | 2.14B | 2.62B | 3.07B | 2.94B |
Total Liabilities | 199.7M | 258.22M | 405.62M | 583.06M | 678.45M |
Total Equity | 1.69B | 1.88B | 2.21B | 2.49B | 2.26B |
Year End December 28 2023 | 2020 | 2021 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 526.96M | 208.98M | 400.8M | 362.61M | 333.32M |
Investing | -587.25M | -131.22M | -42.88M | -524.41M | -26.96M |
Financing | 12.55M | -25.13M | -14.8M | 586k | -546.05M |
Market Cap | 10.11B |
Price to Earnings Ratio | 50.02 |
Price to Sales Ratio | 5.68 |
Price to Cash Ratio | 39.52 |
Price to Book Ratio | 4.59 |
Dividend Yield | - |
Shares Outstanding | 285.58M |
Average Volume (1 week) | 717 |
Average Volume (1 Month) | 695 |
52 Week Change | 77.31% |
52 Week High | 35.40 |
52 Week Low | 17.45 |
Spread (Intraday) | 0.47 (1.34%) |
Company Name | Exelixis Inc Dl 01 |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.exelixis.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.